CasLoc logo
All Cases PTAB Litigations UPC Oppositions

THE MEDICINES COMPANY v. DR. REDDY'S LABORATORIES LTD.

3:11-cv-02456

Overview

Case Number 3:11-cv-02456
Filing Date 2011-04-28
Status Terminated
Termination Date 2017-12-15
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

GLAND PHARMA, INC. Operating Company

Represented By

2 Attorneys Listed

GLAND PHARMA, INC.

PRO SE

PRO SE

MICHAEL H. IMBACUAN

BUDD LARNER, PC

Tel: +1 (973) 379-4800

150 JOHN F. KENNEDY PARKWAY, CN 1000

DR. REDDY'S LABORATORIES LTD. Operating Company

Represented By

2 Attorneys Listed

STUART D. SENDER

BUDD LARNER, PC

Tel: +1 (973) 379-4800

150 JOHN F. KENNEDY PARKWAY, CN 1000

MICHAEL H. IMBACUAN

BUDD LARNER, PC

Tel: +1 (973) 379-4800

150 JOHN F. KENNEDY PARKWAY, CN 1000

SUN PHARMACEUTICAL INDUSTRIES INC. Operating Company

Represented By

1 Attorneys Listed

STEVEN J. LEE

KENYON & KENYON LLP

Tel: +1 (212) 452-7200
Fax: +1 (212) 452-5288

ONE BROADWAY, NEW YORK, NY 10004

SUN PHARMACEUTICAL INDUSTRIES LTD. Operating Company

Represented By

1 Attorneys Listed

STEVEN J. LEE

KENYON & KENYON LLP

Tel: +1 (212) 452-7200
Fax: +1 (212) 452-5288

ONE BROADWAY, NEW YORK, NY 10004

CARACO PHARMACEUTICAL LABORATORIES, LTD. Operating Company

Represented By

1 Attorneys Listed

STEVEN J. LEE

KENYON & KENYON LLP

Tel: +1 (212) 452-7200
Fax: +1 (212) 452-5288

ONE BROADWAY, NEW YORK, NY 10004

DR. REDDY'S LABORATORIES, INC. Operating Company

Represented By

2 Attorneys Listed

STUART D. SENDER

BUDD LARNER, PC

Tel: +1 (973) 379-4800

150 JOHN F. KENNEDY PARKWAY, CN 1000

MICHAEL H. IMBACUAN

BUDD LARNER, PC

Tel: +1 (973) 379-4800

150 JOHN F. KENNEDY PARKWAY, CN 1000

SUN PHARMA GLOBAL FZE Operating Company

Represented By

1 Attorneys Listed

STEVEN J. LEE

KENYON & KENYON LLP

Tel: +1 (212) 452-7200
Fax: +1 (212) 452-5288

ONE BROADWAY, NEW YORK, NY 10004

Plaintiff

THE MEDICINES COMPANY NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

JEFFREY S. SOOS

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

KATHERINE ANN ESCANLAR

SAIBER LLC

Tel: +1 (973) 622-3333

SAIBER LLC, ONE GATEWAY CENTER

RITA DARLENE TURNER

SAIBER LLC

Tel: +1 (973) 622-3333

SAIBER LLC, ONE GATEWAY CENTER

ARNOLD B. CALMANN

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 3 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (1): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2014-04-25
5:14-cv-00058

The Medicines Company v. Exela Pharma Sciences, LLC

Asserted Patent
Status: NCWD
U.S. District Court 2010-08-19
1:10-cv-00700

Medicines Company v. Hospira Inc.

Asserted Patent
Status: DED
U.S. District Court 2009-10-08
1:09-cv-00750

Medicines Company v. Hospira Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7582727
Pharmaceutical formulations of bivalirudin and processes of making the same
Filed: 2008-07-27
Issued: 2009-09-01
Active (1.7 yrs remaining)
Expires: 2028-07-27

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

44

Dispositive

36

Granted

4

Denied

3

Pending / Review

24

Motions by Category

Claim Construction / Markman Filing 7 Motion for Summary Judgment (Rule 56) 26 Procedural / Extension Motion 1 Motion for Summary Judgment (Infringement) 10

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
LETTER ORDER withdrawing 62 Motion for Summary Judgment. Signed by Judge Peter G. Sheridan on 5/14/2013. (mmh) (Entered: 05/14/2013)
Entry #90 • 2013-05-14 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
Letter from M. Imbacuan to J. Sheridan re 62 MOTION for Summary Judgment of Non-Infringement of U.S. Patent Nos. 7,582,727 and 7,598,343. (IMBACUAN, MICHAEL) (E...
Entry #89 • 2013-05-13 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC., GLAND PHARMA, INC. re 62 MOTION for Summary Judgment...
Entry #76 • 2013-02-25 Document →
Motion for Summary Judgment (Infringement) Pending
Set Deadlines as to 75 MOTION to Seal Document 73 Brief in Opposition to Motion,, of Defendants Dr. Reddy's for Summary Judgment of Noninfringement, along with ...
Entry #— • 2013-02-20
Motion for Summary Judgment (Infringement) Pending / Under Review
BRIEF in Opposition filed by THE MEDICINES COMPANY re 62 MOTION for Summary Judgment of Non-Infringement of U.S. Patent Nos. 7,582,727 and 7,598,343 (Attachment...
Entry #73 • 2013-02-19 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
Exhibit to 73 Brief in Opposition to Motion,, by THE MEDICINES COMPANY. (Attachments: # 1 Exhibit 6-14 to the Declaration of Porter F. Fleming in Support of Pla...
Entry #74 • 2013-02-19 Document →

Docket Entries

(196 total)
Pleading / Complaint

COMPLAINT against DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC., GLAND PHARMA, INC. ( Filing fee $ 350 receipt number 3698162.) NO JURY DEMAND., filed by THE MEDICINES COMPANY. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(jjc) (Entered: 04/29/2011)

Entry #1 • 2011-04-28
1

Corporate Disclosure Statement by THE MEDICINES COMPANY identifying NONE as Corporate Parent.. (jjc) (Entered: 05/03/2011)

Entry #4 • 2011-04-28
1

SUMMONS ISSUED as to DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC., GLAND PHARMA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *JAWEIA CAMPBELL* (jjc) (Entered: 04/29/2011)

Entry #2 • 2011-04-29
1

AO120 Patent/Trademark Form filed. (jjc) (Entered: 04/29/2011)

Entry #3 • 2011-04-29
1

CLERK'S QUALITY CONTROL MESSAGE - Please be advised, pursuant to Fed. R. Civ. Pro. 7.1, a disclosure statement is required to be filed by a nongovernmental corporate party. Please refer to the Court's website at www.njd.uscourts.gov for a form and filing instructions. (jjc)

Entry #5 • 2011-04-29
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc